Expression of the proto-oncogene c-myc in human stenotic aortocoronary bypass grafts

Pathology Research and Practice

Volumn 197, Issue 12, 2001, Pages 811-816

  Hilker, Michael ^a   Tellmann, Gudrun ^a   Buerke, Michael ^a   Moersig, Wolfgang ^a   Oelert, Helmut ^a   Lehr, Hans Anton ^a   Hake, Ulrich ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Bypass graft disease; c myc; Proto oncogenes

Indexed keywords

MESSENGER RNA; MYC PROTEIN;

ADULT; AGED; ARTERY ENDOTHELIUM; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE FUNCTION; GRAFT OCCLUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; ONCOGENE C MYC; PATHOPHYSIOLOGY; PROTO ONCOGENE; REOPERATION; SAPHENOUS VEIN; SCORING SYSTEM; VASA VASORUM;

EID: 0035676882     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00164     Document Type: Article

References (34)

1. Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months
2. Oncogenic activity of the c-Myc protein requires dimerization with Max
3. Saphenous vein graft failure: Etiologic considerations and strategies for prevention
4. Mad: A heterodimeric partner for MAx that antagonizes Myc transcriptional activity
5. Down-regulation of the c-myc protooncogene in inhibition of vascular smooth-muscle cell proliferation: A signal for growth arrest?
6. Accelerated "atherosclerosis". A morphologic study of 97 saphenous vein coronary artery bypass grafts
7. Histological and morphometric analyses of early and late aortocoronary vein grafts and distal anastomoses
8. Mechanisms of restenosis
9. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
10. Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration
11. c-myc oncoprotein function
12. Vein graft stenosis
13. c-myc in vasculoproliferative disease
14. Nucleotide sequence of the human c-myc locus: Provocative open reading frame within the first exon
15. The pathogenesis of graft vascular disease: Implications of vascular remodeling
16. The emerging concept of vascular remodeling
17. Insight into atherosclerosis: A review of c-myc and the vascular smooth muscle cell
18. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
19. Antisense strategies to inhibit restenosis
20. Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues
21. E-vivo gene therapy of human vascular bypass grafts with E2F decoy: The PREVENT single-centre, randomised, controlled trial
22. Sustained reduction of neointima with c-myc antisense oligonucleotides in saphenous vein grafts
23. Saphenous vein graft protection: Effects of c-myc antisense
24. Distribution of c-myc oncoprotein in healthy and atherosclerotic human carotid arteries
25. Vein graft failure
26. Molecular and cell biology of native coronary and vein-graft atherosclerosis: Regulation of plaque stability and vessel-wall remodelling by growth factors and cell-extracellular matrix interactions
27. Coronary artery bypass graft disease
28. Molecular and cellular changes in vein grafts: Influence of pulsatile stretch
29. Replication of smooth muscle cells in vascular disease
30. Downregulation of c-myc expression by antisense olignucleotides inhibits proliferation of human smooth muscle cells
31. Topography of cell replication in human vein graft stenoses
32. Immunocytochemical determination of cell type and proliferation rate in human vein graft stenoses
33. Basic cellular mechanisms of coronary bypass graft disease
34. Mouse model of venous bypass graft arteriosclerosis